Works about TOCILIZUMAB

Results: 1277
    1
    2
    3
    4
    5

    Immunobiological effects of tocilizumab across respiratory subphenotypes in COVID-19 ARDS.

    Published in:
    Intensive Care Medicine Experimental, 2025, v. 13, n. 1, p. 1, doi. 10.1186/s40635-025-00779-z
    By:
    • Rademaker, Emma;
    • Filippini, Daan F. L.;
    • Haitsma Mulier, Jelle L. G.;
    • Slim, Marleen A.;
    • van Amstel, Rombout B. E.;
    • Bhavani, Sivasubramanium V.;
    • Juffermans, Nicole P.;
    • de Grooth, Harm-Jan S.;
    • Derde, Lennie P. G.;
    • Cremer, Olaf L.;
    • Bos, Lieuwe D. J.
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Retention rate of a second line with a biologic DMARD after failure of a first-line therapy with abatacept, tocilizumab, or rituximab: results from the Italian GISEA registry.

    Published in:
    Clinical Rheumatology, 2021, v. 40, n. 10, p. 4039, doi. 10.1007/s10067-021-05734-3
    By:
    • Sebastiani, Marco;
    • Venerito, Vincenzo;
    • Bugatti, Serena;
    • Bazzani, Chiara;
    • Biggioggero, Martina;
    • Petricca, Luca;
    • Foti, Rosario;
    • Bortoluzzi, Alessandra;
    • Balduzzi, Silvia;
    • Visalli, Elisa;
    • Frediani, Bruno;
    • Manfredi, Andreina;
    • Gremese, Elisa;
    • Favalli, Ennio;
    • Iannone, Florenzo;
    • Ferraccioli, Gianfranco;
    • Lapadula, Giovanni;
    • Contributors;
    • Galli, Elena;
    • Cantatore, Francesco Paolo
    Publication type:
    Article
    17

    Comparison of the effects of baricitinib and tocilizumab on disease activity in patients with rheumatoid arthritis: a propensity score matching analysis.

    Published in:
    Clinical Rheumatology, 2021, v. 40, n. 8, p. 3143, doi. 10.1007/s10067-021-05815-3
    By:
    • Asai, Shuji;
    • Takahashi, Nobunori;
    • Kobayakawa, Tomonori;
    • Kaneko, Atsushi;
    • Watanabe, Tatsuo;
    • Kato, Takefumi;
    • Nishiume, Tsuyoshi;
    • Ishikawa, Hisato;
    • Yoshioka, Yutaka;
    • Kanayama, Yasuhide;
    • Watanabe, Tsuyoshi;
    • Hirano, Yuji;
    • Hanabayashi, Masahiro;
    • Yabe, Yuichiro;
    • Yokota, Yutaka;
    • Suzuki, Mochihito;
    • Terabe, Kenya;
    • Ishiguro, Naoki;
    • Imagama, Shiro;
    • Kojima, Toshihisa
    Publication type:
    Article
    18
    19
    20
    21
    22
    23

    Long-term, interventional, open-label extension study evaluating the safety of tocilizumab treatment in patients with polyarticular-course juvenile idiopathic arthritis from Poland and Russia who completed the global, international CHERISH trial.

    Published in:
    Clinical Rheumatology, 2018, v. 37, n. 7, p. 1807, doi. 10.1007/s10067-018-4071-9
    By:
    • Opoka-Winiarska, Violetta;
    • Żuber, Zbigniew;
    • Alexeeva, Ekaterina;
    • Chasnyk, Vyacheslav;
    • Nikishina, Irina;
    • Dębowska, Grażyna;
    • Smolewska, Elżbieta
    Publication type:
    Article
    24
    25
    26
    27
    28
    29

    Median time to low disease activity is shorter in tocilizumab combination therapy with csDMARDs as compared to tocilizumab monotherapy in patients with active rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: sub-analysis of the Swiss and Austrian patients from the ACT-SURE study

    Published in:
    Clinical Rheumatology, 2017, v. 36, n. 10, p. 2187, doi. 10.1007/s10067-017-3779-2
    By:
    • Mueller, Ruediger;
    • Graninger, Winfried;
    • Sidiropoulos, Páris;
    • Goger, Christoph;
    • Kempis, Johannes
    Publication type:
    Article
    30
    31
    32
    33

    Multicentric Castleman's disease associated with IgA vasculitis (Henoch-Schönlein purpura) responding well to tocilizumab: a case report.

    Published in:
    Clinical Rheumatology, 2017, v. 36, n. 3, p. 729, doi. 10.1007/s10067-017-3568-y
    By:
    • Oshima, Yoichi;
    • Hoshino, Junichi;
    • Suwabe, Tatsuya;
    • Hayami, Noriko;
    • Yamanouchi, Masayuki;
    • Sekine, Akinari;
    • Ueno, Toshiharu;
    • Mizuno, Hiroki;
    • Yabuuchi, Junko;
    • Imafuku, Aya;
    • Kawada, Masahiro;
    • Hiramatsu, Rikako;
    • Hasegawa, Eiko;
    • Sawa, Naoki;
    • Takaichi, Kenmei;
    • Hayashi, Nobukazu;
    • Fujii, Takeshi;
    • Ubara, Yoshifumi
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48

    Risk of hospitalized infections in older elderly patients with rheumatoid arthritis treated with tocilizumab or other biological/targeted synthetic disease-modifying antirheumatic drugs: Evaluation of data from a Japanese claims database.

    Published in:
    Modern Rheumatology, 2024, v. 34, n. 2, p. 287, doi. 10.1093/mr/road031
    By:
    • Masayoshi Harigai;
    • Takao Fujii;
    • Ryoko Sakai;
    • Ataru Igarashi;
    • Ayako Shoji;
    • Hiroko Yamaguchi;
    • Katsuhiko Iwasaki;
    • Misako Makishima;
    • Amika Yoshida;
    • Norihiro Okada;
    • Katsuhisa Yamashita;
    • Yutaka Kawahito
    Publication type:
    Article
    49
    50